Plain-English translation of NCT05292664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a medication called combined with standard chemotherapy drugs to treat serious blood cancers in children, adolescents, and young adults. The study has three groups based on the type of blood cancer and individual risk factors. Researchers want to find the safest and most effective dose of this medication when combined with other cancer treatments.
Some blood cancers are very hard to treat and don't respond well to standard therapy alone. This trial hopes to find out if adding this medication to existing treatments can help more patients achieve remission and improve survival.
You likely qualify if…
You likely don't qualify if…
You will have screening visits to confirm you qualify, then begin receiving the medication and chemotherapy in 28-day treatment cycles for up to 4 cycles. Your treatment plan depends on which study group you're in and how well earlier participants tolerated the doses. You will have regular visits for evaluations, blood tests, and check-ups to monitor how the treatment is working and watch for side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States